5q-, twenty-five years later: A synopsis

Cancer Genetics and Cytogenetics

Volumn 94, Issue 1, 1997, Pages 1-7

  Van Den Berghe, Herman ^a,c   Michaux, Lucienne ^a,b  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^c CENTER FOR HUMAN GENETICS   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; CANCER SURVIVAL; CHROMOSOME 5Q; CHROMOSOME DELETION 5; GENE DELETION; GENE LOCUS; GENETIC SUSCEPTIBILITY; HUMAN; LEUKEMOGENESIS; LYMPHOPROLIFERATIVE DISEASE; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; PROGNOSIS; REFRACTORY ANEMIA; REVIEW;

EID: 0030934892     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(96)00350-0     Document Type: Article

References (37)

1. Van Den Berghe H, Cassiman JJ, David G, Fryns JP, Michaux JL, Sokal G (1974): Distinct haematological disorder with deletion of long arm of No. 5 chromosome. Nature 251:437-438.
2. Sokal G, Michaux JL, Van den Berghe H, Cordier A, Rodhain J, Ferrant A, Moriau M, Sonnet J (1975): A new hematologic syndrome with a distinct karyotype: The 5q- chromosome. Blood 46:519-533.
3. Van den Berghe H, Vermaelen K, Mecucci C, Barbieri D, Tricot G (1985): The 5q- anomaly. Cancer Genet Cytogenet 17: 189-255.
4. Pedersen B, Jensen IM (1991): Clinical and prognostic implications of 5q deletions: 96 high resolution studied patients. Leukemia 5:566-573.
5. Juneja HS, Jodhani M, Gardner FH, Trevarthen D, Schottstedt M (1994): Low-dose ARA-C consistently induced hematologic responses in the clinical 5q- syndrome. Am J Hematol 56:338-342.
6. Cuneo A, Ferrant A, Michaux JL, Boogaerts M, Demuynck H, Van Orshoven A, Criel A, Stul M, Dal Cin P, Hernandez J, Chatelain B, Doyen C, Louwagie A, Castoldi G, Cassiman JJ, Van den Berghe H (1995): Cytogenetic profile of minimally differentiated (FAB M0) acute myeloid leukemia: Correlation with clinicobiological findings. Blood 85:3688-3694.
7. Le Beau MM (1992): Deletions of chromosome 5 in malignant myeloid disorders. Cancer Surveys 15:143-159.
8. Pedersen-Bjergaard J, Pedersen M, Roulston D, Philip B (1995): Different genetic pathways in leukemogenesis for patients presenting with therapy-related myelodysplasia and therapy-related acute myeloid leukemia. Blood 86:3542-3552.
9. Pedersen-Bjergaard J, Philip P, Olesen-Larsen S, Jensen G, Byrsting K (1990): Chromosome aberrations and prognostic factors in therapy-related myelodysplasia and acute nonlymphocytic leukemia. Blood 76:1083.
10. Abrahamson G, Boultwood J, Madden J, Kelly S, Oscier DG, Rack K, Buckle VJ, Wainscoat JS (1991): Clonality of cell populations in refractory anaemia using combined approach of gene loss and X-linked restriction fragment length polymorphism-methylation analysis. Br J Haematol 79:550-555.
11. Kroef MJPL, Fibbe WE, Mout R, Jansen RPM, Haak HL, Wessels JW, Van Kamp H, Willemze R, Landegent JE (1993): Myeloid but not lymphoid cells carry the 5q- deletion: Polymerase chain reaction analysis of loss of heterozygosity using mini-repeat sequences on highly purified cell fractions. Blood 81:1849-1854.
12. Fairman J, Chumakow I, Craig-Chinault A, Nowell P, Nagarajan L (1995): Physical mapping of the minimal region of loss in 5q- chromosome. Proc Natl Acad Sci U S A 1995:7406-7410.
13. Fiedler W, Weh HJ, Zeller W, Fonatsch C, Hillion J, Larsen C, Wörmann B, Hossfeld DK (1991): Translocation (14;18) and (8;22) in three patients with acute leukemia/lymphoma following centrocytic/centroblastic non-Hodgkin's lymphoma. Ann Hematol 63:282-287.
14. Gladstone B, Kadam PR, Balsara BR, Pai SK, Gopal R, Nair CN, Parikh PM, Saikia T, Advani SH (1994): Cytogenetic studies on patients of acute lymphoblastic leukemia Burkitt's type with (8;14) and (14:18) translocations. Ind J Med Res 99:264-266.
15. McCarthy CM, Cobcroft RG, Harris MG, Scott DC (1987): Sweet's syndrome, acute leukemia and t(3;5). Cancer Genet Cytogenet 28:87-91.
16. Raimondi SC, Dube ID, Valentine MB, Mirro J Jr, Watt HJ, Larson RA, Bitter MA, Le Beau MM, Rowley JD (1989): Clinicopathologic manifestations and breakpoints of the t(3;5) in patients with acute nonlymphocytic leukemia. Leukemia 3: 42-47.
17. Billstrom R, Heim S, Kristofferson U, Mandahl N, Mitelman F (1990): Structural chromosomal abnormalities of 3q in myelodysplastic syndrome/acute myeloid leukemia with Sweet's syndrome. Eur J Haematol 45:150-152.
18. Morris SW, Foust JT, Valentine M, Roberts WM, Shapiro DN, Look AT (1992): Sublocalization of the chromosome 5 breakpoint of the 3;5 translocation in myelodysplasia syndromes and acute myeloid leukemia. Genes Chromosom Cancer 5:385-396.
19. Mecucci C, Van den Berghe H, Michaux JL, Bosly A, Doyen C (1987): Paracentric inversions on the long arm of chromosome 5 in secondary myelodysplastic disorders. Cancer Genet Cytogenet 29:171-173.
20. Huebner K, Nagarajan L, Besa E, Angert E, Lange BJ, Cannizzaro LA, Van den Berghe H, Santoli D, Finan J, Croce CM, Nowell PC (1990): Order of genes on human chromosome 5q with respect to 5q interstitial deletions. Am J Hum Genet 46:26-36.
21. Golub TR, Barker GF, Lovett M, Gilliland DG (1994): Fusion of PDGF receptor beta to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation. Cell 77:307-316.
22. Morris S, Kirstein M, Valentine M, Dittmer KG, Shapiro DN, Salltman DL, Look AT (1994): Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. Science 263:1282.
23. Le Beau MM (1992): Deletions of chromosome 5 in malignant myeloid disorders. In: Cancer Surveys, vol 15: Oncogenes in the Development of Leukemia. Imperial Cancer Research Fund, pp. 143-159.
24. Pedersen B (1993): 5q-: Pathogenetic importance of the common deleted region and clinical consequences of the entire deleted segment. Anticancer Res 13:1913-1916.
25. Nagarajan L (1995): Molecular analysis of the 5q- chromosome. Leuk Lymph 17:361-366.
26. Willman CL, Sever CE, Pallavicini MG, Harada H, Tanaka N, Slovak ML, Yamamoto H, Harada K, Meeker T, List AF, Taniguchi T (1993): Deletion of IRF-1, mapping to chromosome 5q31.1, in human leukemia and preleukemic myelodysplasia. Science 259:968-971.
27. Beretta L, Gabbay M, Berger R, Hanasch SM, Sonenberg N (1996): Expression of the protein kinase PKR is modulated by IRF-1 and is reduced in 5q- associated leukemias. Oncogene 12:1593-1596.
28. Boultwood J, Fidler C, Lewis S, MacCarthy KA, Sheridan H, Kelly S, Oscier D, Buckle UJ, Wainscoat JKS (1993): Allelic loss of IRF1 in myelodysplasia and acute myeloid leukemia. Retention of IRF1 on the 5q- chromosome in some patients with the 5q- syndrome. Blood 82:2611-2616.
29. Boultwood J, Rack K, Kelly S, Maddens J, Sakaguchi AY, Wang L-M, Oscier DG, Buckle VJ, Wainscoat JS (1991): Loss of both CSF1R (FMS) alleles in patients with myelodysplasia and a chromosome 5 deletion. Proc Natl Acad Sci U S A 88:6176-6180.
30. Ridge SA, Worwood M, Oscier D, Jacobs A, Padua RA (1990): FMS mutations in myelodysplastic, leukemic and normal subjects. Proc Natl Acad Sci U S A 87:1377-1380.
31. Roussel MF, Downing JR, Rettenmier CW, Sherr CJ (1988): A point mutation in the extracellular domain of the human CSF-1 receptor activates its transforming potential. Cell 55: 979-988.
32. Jacobs A (1991): Genetic lesions in preleukemia. Leukemia 5:277-282.
33. Morris C, Heisterkamp N, Hao QL, Testa JR, Groffen J (1990): The human tyrosine kinase gene (FER) maps to chromosome 5 and is deleted in myeloid leukemias with a del(5q). Cytogenet Cell Genet 53:196-200.
34. Le Beau MM, Espinoza III R, Neuman WL, Stock W, Roulston D, Larson RA, Keinanen M, Westbrook C (1993): Cytogenetic and molecular delineation of the smallest commonly deleted region of chromosome 5 in malignant myeloid disease. Proc Natl Acad Sci U S A 90:5484-5488.
35. Nagarajan L, Zavadil J, Claxton D, Lu X, Fairman J, Warrington JA, Wasmuth JJ, Chinault AC, Sever CE, Slovak ML, Willman CL, Deisseroth AB (1994): Consistent loss of the D5S89 locus mapping telomeric to the interleukin gene cluster and centromeric to EGR-1 in patients with 5q- chromosome. Blood 83:199-208.
36. Nagarajan L, Zhao L, Lu X, Warrington J, Wasmuth JJ, Siciliano M, Deisseroth AB, Liang JC (1994): 5q- chromosome. Cancer Genet Cytogenet 74:8-12.
37. Mitelman F (1994): Catalog of Chromosome Aberrations in Cancer. ed 5. Wiley-Liss, New York.